Study identifier:D3250C00057
ClinicalTrials.gov identifier:NCT03588546
EudraCT identifier:N/A
CTIS identifier:N/A
FASENRA Subcutaneous Injection 30 mg Syringe Specific Clinical Experience Investigation for long-term use
asthma
N/A
No
-
All
653
Observational
n/a - n/a
Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Sept 2024 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|